276 related articles for article (PubMed ID: 19266027)
21. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries.
Grigg ME; Bonnefoy S; Hehl AB; Suzuki Y; Boothroyd JC
Science; 2001 Oct; 294(5540):161-5. PubMed ID: 11588262
[TBL] [Abstract][Full Text] [Related]
22. The Toxoplasma gondii rhoptry protein ROP18 is an Irga6-specific kinase and regulated by the dense granule protein GRA7.
Hermanns T; Müller UB; Könen-Waisman S; Howard JC; Steinfeldt T
Cell Microbiol; 2016 Feb; 18(2):244-59. PubMed ID: 26247512
[TBL] [Abstract][Full Text] [Related]
23. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response.
Niedelman W; Gold DA; Rosowski EE; Sprokholt JK; Lim D; Farid Arenas A; Melo MB; Spooner E; Yaffe MB; Saeij JP
PLoS Pathog; 2012; 8(6):e1002784. PubMed ID: 22761577
[TBL] [Abstract][Full Text] [Related]
24. Polymorphic secreted kinases are key virulence factors in toxoplasmosis.
Saeij JP; Boyle JP; Coller S; Taylor S; Sibley LD; Brooke-Powell ET; Ajioka JW; Boothroyd JC
Science; 2006 Dec; 314(5806):1780-3. PubMed ID: 17170306
[TBL] [Abstract][Full Text] [Related]
25. Toxoplasma gondii, "new" genotypes and virulence.
Dardé ML
Parasite; 2008 Sep; 15(3):366-71. PubMed ID: 18814708
[TBL] [Abstract][Full Text] [Related]
26. WITHDRAWN: Toxoplasma gondii virulence factor ROP18 inhibits the host NF-κB pathway by promoting p65 degradation.
Du J; An R; Chen L; Shen Y; Chen Y; Cheng L; Jiang Z; Zhang A; Yu L; Chu D; Shen Y; Luo Q; Chen H; Wan L; Li M; Xu X; Shen J
J Biol Chem; 2014 May; 289(18):12578-92. PubMed ID: 24648522
[TBL] [Abstract][Full Text] [Related]
27. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii.
Behnke MS; Dubey JP; Sibley LD
Annu Rev Microbiol; 2016 Sep; 70():63-81. PubMed ID: 27359216
[TBL] [Abstract][Full Text] [Related]
28. The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii.
Fentress SJ; Steinfeldt T; Howard JC; Sibley LD
Cell Microbiol; 2012 Dec; 14(12):1921-33. PubMed ID: 22906355
[TBL] [Abstract][Full Text] [Related]
29. Influence of Two Major
Hernández-de-Los-Ríos A; Murillo-Leon M; Mantilla-Muriel LE; Arenas AF; Vargas-Montes M; Cardona N; de-la-Torre A; Sepúlveda-Arias JC; Gómez-Marín JE
Front Cell Infect Microbiol; 2019; 9():413. PubMed ID: 31867288
[No Abstract] [Full Text] [Related]
30. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence.
Reese ML; Zeiner GM; Saeij JP; Boothroyd JC; Boyle JP
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9625-30. PubMed ID: 21436047
[TBL] [Abstract][Full Text] [Related]
31. A monomorphic haplotype of chromosome Ia is associated with widespread success in clonal and nonclonal populations of Toxoplasma gondii.
Khan A; Miller N; Roos DS; Dubey JP; Ajzenberg D; Dardé ML; Ajioka JW; Rosenthal B; Sibley LD
mBio; 2011; 2(6):e00228-11. PubMed ID: 22068979
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse.
Lilue J; Müller UB; Steinfeldt T; Howard JC
Elife; 2013 Oct; 2():e01298. PubMed ID: 24175088
[TBL] [Abstract][Full Text] [Related]
33. Structure of the Toxoplasma gondii ROP18 kinase domain reveals a second ligand binding pocket required for acute virulence.
Lim D; Gold DA; Julien L; Rosowski EE; Niedelman W; Yaffe MB; Saeij JP
J Biol Chem; 2013 Nov; 288(48):34968-80. PubMed ID: 24129568
[TBL] [Abstract][Full Text] [Related]
34. ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.
Yamamoto M; Ma JS; Mueller C; Kamiyama N; Saiga H; Kubo E; Kimura T; Okamoto T; Okuyama M; Kayama H; Nagamune K; Takashima S; Matsuura Y; Soldati-Favre D; Takeda K
J Exp Med; 2011 Jul; 208(7):1533-46. PubMed ID: 21670204
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening.
Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J
Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024
[TBL] [Abstract][Full Text] [Related]
36. Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.
Sibley LD; Mordue DG; Su C; Robben PM; Howe DK
Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):81-8. PubMed ID: 11839185
[TBL] [Abstract][Full Text] [Related]
37. Molecular and biological analysis revealed genetic diversity and high virulence strain of Toxoplasma gondii in Japan.
Fukumoto J; Yamano A; Matsuzaki M; Kyan H; Masatani T; Matsuo T; Matsui T; Murakami M; Takashima Y; Matsubara R; Tahara M; Sakura T; Takeuchi F; Nagamune K
PLoS One; 2020; 15(2):e0227749. PubMed ID: 32012177
[TBL] [Abstract][Full Text] [Related]
38. A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins.
Fleckenstein MC; Reese ML; Könen-Waisman S; Boothroyd JC; Howard JC; Steinfeldt T
PLoS Biol; 2012; 10(7):e1001358. PubMed ID: 22802726
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasma's arms race with the host interferon response: a ménage à trois of ROPs.
Zhao Y; Yap GS
Cell Host Microbe; 2014 May; 15(5):517-8. PubMed ID: 24832444
[TBL] [Abstract][Full Text] [Related]
40. Overlapping Toxoplasma gondii genotypes circulating in domestic animals and humans in Southeastern Brazil.
Silva LA; Andrade RO; Carneiro AC; Vitor RW
PLoS One; 2014; 9(2):e90237. PubMed ID: 24587295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
